COWINTECH Co. Ltd. (KOSDAQ:282880)
9,840.00
+30.00 (0.31%)
At close: Aug 20, 2026
COWINTECH Revenue
COWINTECH had revenue of 39.80B KRW in the quarter ending March 31, 2026, with 50.82% growth. This brings the company's revenue in the last twelve months to 168.11B, down -22.65% year-over-year. In the year 2025, COWINTECH had annual revenue of 154.70B, down -36.70%.
Revenue (ttm)
168.11B
Revenue Growth
-22.65%
P/S Ratio
0.67
Revenue / Employee
683.38M
Employees
246
Market Cap
112.72B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 154.70B | -89.69B | -36.70% |
| Dec 31, 2024 | 244.39B | -91.57B | -27.26% |
| Dec 31, 2023 | 335.96B | 134.80B | 67.01% |
| Dec 31, 2022 | 201.15B | 94.81B | 89.14% |
| Dec 31, 2021 | 106.35B | 61.00B | 134.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KCC Engineering & Construction | 1.28T |
| KX Innovation | 354.87B |
| HLB Pharmaceutical | 236.59B |
| Keeps Biopharma | 188.94B |
| Kookjeon Pharmaceutical | 127.43B |
| Ibkimyoung | 120.91B |
| Knowmerce | 75.16B |
| High Tech Pharm | 69.05B |